Kejako
Geneve
About Kejako
Kejako develops a non-invasive solution for interested presbyopic patients seeking to keep their quality of life through the compensation of visual accommodation decay. Addressing presbyopia in the field of ophthalmology, with an anti-aging mindset in order to treat the gradual loss of visual accommodation. Kejako SA is a privately held company founded in March 2015 and based in Geneva, Switzerland. The company address presbyopia in the field of ophthalmology with a breakthrough approach combining simulation and minimally invasive treatment: all-in-one solution.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Seed (Aug 2022)
- Website: kejako.com
Industries & Categories
Biotechnology, Health Care, Medical Device, Wellness
Social Profiles
Canonical: https://fsome.com/organization/kejako-149537 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.